Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells

被引：0
|
作者：
Kim, Donghwa [1 ]
Bach, Duc-Hiep [1 ]
Hong, Ji-Young [1 ]
Park, Hyen Joo [1 ]
Lee, Sang Kook [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
894
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer
    Bae, Song Yi
    Hong, Ji-Young
    Lee, Hye-Jung
    Park, Hyen Joo
    Lee, Sang Kook
    ONCOTARGET, 2015, 6 (12) : 10146 - 10160
  • [2] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [3] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [4] Degradation of AXL overcome acquired cross-resistance to gefitinib and osimertinib in non-small cell lung cancer cells
    Kim, Donghwa
    Bach, Duc-Hiep
    Fan, Yan-hua
    Luu, Thi-Thu-Trang
    Hong, Ji-Young
    Park, Hyen-Joo
    Lee, Sang Kook
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
    Sin, Thomas K.
    Wang, Fengfeng
    Meng, Fei
    Wong, S. C. Cesar
    Cho, William C. S.
    Siu, Parco M.
    Chan, Lawrence W. C.
    Yung, Benjamin Y. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [6] Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
    Heasley, Lynn E.
    Marek, Lindsay
    Fritzsche, Alexa
    Helton, Wallace R.
    Nemenoff, Raphael A.
    McDermott, Lee A.
    Helfrich, Barbara
    Bunn, Paul A.
    FASEB JOURNAL, 2008, 22
  • [7] The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
    Mohiuddin, Md
    Kasahara, Kazuo
    CANCER GENOMICS & PROTEOMICS, 2021, 18 (05) : 661 - 673
  • [8] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [9] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [10] Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway
    Li, Xia
    Fan, Xing-Xing
    Jiang, Ze-Bo
    Loo, Wings T. Y.
    Yao, Xiao-Jun
    Leung, Elaine Lai-Han
    Chow, Louis W. C.
    Liu, Liang
    PHARMACOLOGICAL RESEARCH, 2017, 115 : 45 - 55
12345